|
|
||||||||



*
Department of Pathology, Vrÿe Universiteit University Hospital, Amsterdam, The Netherlands; and
Swammerdam Institute for Life Sciences, University of Amsterdam, Amsterdam, The Netherlands
BMI-1 and EZH2 Polycomb-group (PcG) proteins belong to two distinct protein complexes involved in the regulation of hematopoiesis. Using unique PcG-specific antisera and triple immunofluorescence, we found that mature resting peripheral T cells expressed BMI-1, whereas dividing blasts were EZH2+. By contrast, subcapsular immature double-negative (DN) (CD4-/CD8-) T cells in the thymus coexpressed BMI-1 and EZH2 or were BMI-1 single positive. Their descendants, double-positive (DP; CD4+/CD8+) cortical thymocytes, expressed EZH2 without BMI-1. Most EZH2+ DN and DP thymocytes were dividing, while DN BMI-1+/EZH2- thymocytes were resting and proliferation was occasionally noted in DN BMI-1+/EZH2+ cells. Maturation of DP cortical thymocytes to single-positive (CD4+/CD8- or CD8+/CD4-) medullar thymocytes correlated with decreased detectability of EZH2 and continued relative absence of BMI-1. Our data show that BMI-1 and EZH2 expression in mature peripheral T cells is mutually exclusive and linked to proliferation status, and that this pattern is not yet established in thymocytes of the cortex and medulla. T cell stage-specific PcG expression profiles suggest that PcG genes contribute to regulation of T cell differentiation. They probably reflect stabilization of cell type-specific gene expression and irreversibility of lineage choice. The difference in PcG expression between medullar thymocytes and mature interfollicular T cells indicates that additional maturation processes occur after thymocyte transportation from the thymus.
This article has been cited by other articles:
![]() |
J. Silva, J. M. Garcia, C. Pena, V. Garcia, G. Dominguez, D. Suarez, F. I. Camacho, R. Espinosa, M. Provencio, P. Espana, et al. Implication of Polycomb Members Bmi-1, Mel-18, and Hpc-2 in the Regulation of p16INK4a, p14ARF, h-TERT, and c-Myc Expression in Primary Breast Carcinomas Clin. Cancer Res., December 1, 2006; 12(23): 6929 - 6936. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Raaphorst Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors Hum. Mol. Genet., April 15, 2005; 14(suppl_1): R93 - R100. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Dukers, J. C. van Galen, C. Giroth, P. Jansen, R. G.A.B. Sewalt, A. P. Otte, H. C. Kluin-Nelemans, C. J.L.M. Meijer, and F. M. Raaphorst Unique Polycomb Gene Expression Pattern in Hodgkin's Lymphoma and Hodgkin's Lymphoma-Derived Cell Lines Am. J. Pathol., March 1, 2004; 164(3): 873 - 881. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Raaphorst, M. Vermeer, E. Fieret, T. Blokzijl, D. Dukers, R. G.A.B. Sewalt, A. P. Otte, R. Willemze, and C. J.L.M. Meijer Site-Specific Expression of Polycomb-Group Genes Encoding the HPC-HPH/PRC1 Complex in Clinically Defined Primary Nodal and Cutaneous Large B-Cell Lymphomas Am. J. Pathol., February 1, 2004; 164(2): 533 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamamoto, M. Sonoda, J. Inokuchi, S. Shirasawa, and T. Sasazuki Polycomb Group Suppressor of Zeste 12 Links Heterochromatin Protein 1{alpha} and Enhancer of Zeste 2 J. Biol. Chem., January 2, 2004; 279(1): 401 - 406. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Otte and M. van Lohuizen Correspondence re: S. Bea et al., BMI-1 Gene Amplification and Overexpression in Hematological Malignancies Occur Mainly in Mantle Cell Lymphomas. Cancer Res., 61: 2409-2412, 2001 Cancer Res., January 1, 2002; 62(2): 618 - 618. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |